Anti-IL2 Induction in Liver Transplantation with 93% Rejection-Free Patient and Graft Survival at 18 Months
Presented at the 1st Annual Academic Surgical Congress (Association for Academic Surgery), San Diego, CA, February 7–11, 2006.
Division of Transplantation, Department of Surgery, Jefferson Medical College and Thomas Jefferson University Hospital, Philadelphia, Pennsylvania
Received 12 January 2006 published online 10 February 2007.
PII: S0022-4804(06)00465-3
doi:10.1016/j.jss.2006.08.025
© 2007 Elsevier Inc. All rights reserved.
http://s7.addthis.com/js/250/addthis_widget.js#pub=xa-4b1d65bd00983246Access this article on
SciVerse ScienceDirect
Visit SciVerse ScienceDirect to see if you have access via your institution.